Upregulation of key factors of viral entry of corona‐ and influenza viruses upon TLR3 ‐signaling in cells from the respiratory tract and clinical treatment options by 1,8‐Cineol
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8280 ↗At a glance
Journal article in Phytotherapy Research, 2024. Written by Leonie Hose and 2 co-authors. Institution: Department of Otolaryngology, Head and Neck Surgery, Campus Klinikum Bielefeld Mitte, University Hospital OWL of Bielefeld University, Bielefeld, Ger…. Major MEDLINE topics: Toll-Like Receptor 3, Virus Internalization, Serine Endopeptidases, Angiotensin-Converting Enzyme 2. Cited 3 times so far (Crossref); 106 references. The full text is freely available (open access, CC BY 4.0). Funded by: Bundesministerium für Bildung und Forschung, Cassella-med Pharma GmbH.
Abstract (original language)
At the end of the 2019 coronavirus pandemic (COVID‐19), highly contagious variants of coronaviruses had emerged. Together with influenza viruses, different variants of the coronavirus currently cause most colds and require appropriate drug treatment. We have investigated the expression of important factors for the replication of these viruses, namely transmembrane protease serine subtype 2 (TMPRSS2), neuropilin1 (NRP1), and angiotensin converting enzyme 2 (ACE2) or tumor necrosis factor‐α (TNF‐α) after toll like receptor‐3 (TLR‐3) stimulation using RT‐qPCR and flow cytometry (FC) analysis. As model served primary fibroblasts derived from the lung and nasal cavity, as well as epidermal stem cells and fully matured respiratory epithelium. The stimulated cell cultures were treated with pharmaceuticals (Dexamethasone and Enzalutamide) and the outcome was compared with the phytomedicine 1,8‐Cineol. The stimulation of TLR3 is sufficient to induce the expression of exactly those targets that were highly expressed in the corresponding culture type, specifically ACE2 and TMPRSS2 in respiratory epithelial stem cells and NRP1 in fibroblast cells. It seems this self‐perpetuating cycle of infection‐driven upregulation of key viral replication factors by the innate immune system represents an evolutionary advantage for viruses using these transcripts as viral replication factors. Likewise, to the standard pharmaceuticals with proven clinical efficiency, 1,8‐Cineol was able to disrupt this self‐perpetuating cycle. Considering the minor side effects and negligible pharmacological interactions with other drugs, it is conceivable that an adjuvant or combinatorial therapy with 1,8‐Cineol for respiratory diseases caused by corona‐ or influenza viruses would be beneficial.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otolaryngology, Head and Neck Surgery, Campus Klinikum Bielefeld Mitte, University Hospital OWL of Bielefeld University, Bielefeld, Germany.
ORCID profiles: Matthias Schürmann
Funding
- Bundesministerium für Bildung und Forschung
- Cassella-med Pharma GmbH
Cite
APA
Hose, L., Schürmann, M., & Sudhoff, H. (2024). Upregulation of key factors of viral entry of corona‐ and influenza viruses upon TLR3 ‐signaling in cells from the respiratory tract and clinical treatment options by 1,8‐Cineol. Phytotherapy Research. https://doi.org/10.1002/ptr.8280
Vancouver
Hose L, Schürmann M, Sudhoff H. Upregulation of key factors of viral entry of corona‐ and influenza viruses upon TLR3 ‐signaling in cells from the respiratory tract and clinical treatment options by 1,8‐Cineol. Phytotherapy Research. 2024. doi:10.1002/ptr.8280
BibTeX
@article{Hose2024,
author = {Hose, Leonie and Schürmann, Matthias and Sudhoff, Holger},
title = {Upregulation of key factors of viral entry of corona‐ and influenza viruses upon TLR3 ‐signaling in cells from the respiratory tract and clinical treatment options by 1,8‐Cineol},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8280}
}
EUVIMED